JournalsHub
.online
Find My Journal
AP

A Płużańska

Independent Researcher

163
Publications
18,317
Citations
35
H-Index
44
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

163 total

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival PDF

Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, A Płużańska et al. - Nature Medicine, 2012
Cited by 781 OpenAlex

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Luca Gianni, Urania Dafni, Richard D. Gelber, Evandro de Azambuja, Susanne Muehlbauer et al. - The Lancet Oncology, 2011
Cited by 611 OpenAlex

Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment PDF

Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz, Johann Petrus Jordaan, Antonio Llombart‐Cussac et al. - Journal of Clinical Oncology, 2008
Cited by 422 OpenAlex

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bernard Escudier, A Płużańska, P. Koralewski, Alain Ravaud, Sergio Bracarda et al. - The Lancet, 2007
Cited by 2,221 OpenAlex

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial PDF

U. Gatzemeier, A Płużańska, Aleksandra Szczęsna, E. Kaukel, Jaromı́r Roubec et al. - Journal of Clinical Oncology, 2007
Cited by 879 OpenAlex

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry, J Horti, A Płużańska et al. - New England Journal of Medicine, 2004
Cited by 5,710 OpenAlex

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 PDF

Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio V. Scagliotti, Rafael Rosell et al. - Journal of Clinical Oncology, 2004
Cited by 1,720 OpenAlex

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Frank V. Fossella, Jose R. Pereira, Joachim von Pawel, A Płużańska, Vera Gorbounova et al. - Journal of Clinical Oncology, 2003
Cited by 943 OpenAlex

Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, R. Pérez-Carrión, C. Boni et al. - Journal of Clinical Oncology, 2003
Cited by 745 OpenAlex

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group PDF

Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun, R. Pérez-Carrión, C. Boni et al. - Journal of Clinical Oncology, 2001
Cited by 1,016 OpenAlex

Research Topics

Cancer Treatment and Pharmacology (28) Lung Cancer Treatments and Mutations (21) Lymphoma Diagnosis and Treatment (17) Breast Cancer Treatment Studies (15) HER2/EGFR in Cancer Research (9)

Affiliations

BC Cancer Agency
CA 2004 - 2004
University of Helsinki
FI 2002 - 2002
Uppsala University Hospital
SE 2002 - 2002
Heidelberg University
DE 2004 - 2004
Leicester Royal Infirmary
GB 2005 - 2005

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now